| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/29/2014 | EP2688586A2 Plasmodium falciparum antigens |
| 01/29/2014 | EP2688585A1 Methods and compositions for improving antiangiogenic therapy with anti-integrins |
| 01/29/2014 | EP2688578A2 Mia (melanoma inhibitory activity) inhibitors for detecting, preventing and curing vitiligo |
| 01/29/2014 | EP2688574A1 Method of screening antiretroviral compounds and vaccine |
| 01/29/2014 | EP2344537B1 Bispecific anti-vegf/anti-ang-2 antibodies |
| 01/29/2014 | EP2192917B1 Method for producing viral vaccines |
| 01/29/2014 | EP2041180B1 Ilt3 binding molecules and uses therefor |
| 01/29/2014 | DE202006021242U1 Emulsionen mit freiem wässrigen Phasen Tensid als Adjuvans für Spalt-Grippeimpfstoffe Emulsions with free aqueous phase surfactant as an adjuvant for influenza vaccines gap |
| 01/29/2014 | CN103547676A Immunogenic compositions in particulate form and methods for producing the same |
| 01/29/2014 | CN103547675A Immunostimulatory oligodeoxynucleotides |
| 01/29/2014 | CN103547674A Immunostimulatory oligodeoxynucleotides |
| 01/29/2014 | CN103547598A Combination therapies comprising anti-ERBB 3 agents |
| 01/29/2014 | CN103547592A Methods of treating immune disorders with single domain antibodies against TNF-alpha |
| 01/29/2014 | CN103547289A Methods and compositions for treating alzheimer's disease |
| 01/29/2014 | CN103547288A Stem cell factor inhibitor |
| 01/29/2014 | CN103547287A Suppression of a hypersensitivity immune response with unrelated antigen derived from allergen source material |
| 01/29/2014 | CN103547285A Immortalized avian cell lines and use thereof |
| 01/29/2014 | CN103547284A Immunity inducing agent |
| 01/29/2014 | CN103547283A HLA-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof |
| 01/29/2014 | CN103547278A Immunity induction agent |
| 01/29/2014 | CN103540654A Applications of 11-19 lysine-rich leukemia (ELL) gene and expression product thereof |
| 01/29/2014 | CN103540653A Applications of homeobox A1 (HOXA1) gene and expression product thereof |
| 01/29/2014 | CN103540632A Method for production of antibody |
| 01/29/2014 | CN103540614A Signal for packaging of influenza virus vectors |
| 01/29/2014 | CN103540613A Multi plasmid system for the production of influenza virus |
| 01/29/2014 | CN103540605A Capsid protein phage display particle of recombinant II porcine circovirus as well as preparation method and application thereof |
| 01/29/2014 | CN103540604A Building method of deoxyribonucleic acid (DNA) replicor vaccine vector of swine Japanese encephalitis virus and use thereof |
| 01/29/2014 | CN103540568A Multi plasmid system for the production of influenza virus |
| 01/29/2014 | CN103539859A Self-assembled polypeptide nanometer for preparing contraception vaccine |
| 01/29/2014 | CN103539858A Connective tissue growth factor antibodies |
| 01/29/2014 | CN103539857A Antibodies against amyloid-beta peptide |
| 01/29/2014 | CN103539842A Recombinant protein coded by grass carp reovirus (GCRV) type-II S10 gene, polyclonal antibody prepared from recombinant protein and application of recombinant protein |
| 01/29/2014 | CN103539840A Epidermal growth factor receptor (EGFR) mimotope peptide and application thereof |
| 01/29/2014 | CN103539839A Neutralizing epitope peptide of enterovirus 71-type VP2 antigen and application thereof |
| 01/29/2014 | CN103536917A Use of interferon in treatment of tumor, and related product and method |
| 01/29/2014 | CN103536916A Methods for treating tweak-related conditions |
| 01/29/2014 | CN103536915A Compositions and methods for the treatment of infections and tumors |
| 01/29/2014 | CN103536914A Multivalent pcv2 immunogenic compositions and methods of producing such compositions |
| 01/29/2014 | CN103536913A Method for producing avian influenza virus bivalent inactivated vaccine by use of MDCK cell line |
| 01/29/2014 | CN103536912A Porcine circovirus II-type (PCV2) epitope peptide vaccine and preparation method thereof |
| 01/29/2014 | CN103536911A Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| 01/29/2014 | CN103536572A Bacillus calmette-guerin tablet |
| 01/29/2014 | CN102757941B Hepatitis A virus strain HAV-ZL2012, vaccine prepared by using same and application thereof |
| 01/29/2014 | CN102603891B Method for preparing tetanus human immune globulin by double virus inactivation |
| 01/29/2014 | CN102443552B Porcine actinobacillus pleuropeumoniae ClpP protease gene-deleted strain containing no resistance marker, construction method thereof, and application thereof |
| 01/29/2014 | CN102382845B Method for producing porcine parvovirus antigen and its product |
| 01/29/2014 | CN101765610B Novel immunogenic epitopes for immunotherapy, preparation method and uses |
| 01/29/2014 | CN101563361B Influenza viruses able to infect canids, uses thereof |
| 01/29/2014 | CN101541833B Il-17 receptor a antigen binding proteins |
| 01/29/2014 | CN101400406B Compositions and methods of use for antibodies of dickkopf-1 and/or -4 |
| 01/28/2014 | US8637659 Mono-and disaccharide derivatives |
| 01/28/2014 | US8637645 H5 subtype-specific binding proteins useful for H5 avian influenza diagnosis and surveillance |
| 01/28/2014 | US8637644 H5 subtype-specific binding proteins useful for H5 avian influenza diagnosis and surveillance |
| 01/28/2014 | US8637642 Antibody drug conjugates (ADC) that bind to 191P4D12 proteins |
| 01/28/2014 | US8637469 Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors |
| 01/28/2014 | US8637305 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 01/28/2014 | US8637234 Molecular scaffolds for HIV-1 epitopes |
| 01/28/2014 | US8637053 Chlamydia antigens |
| 01/28/2014 | US8637052 Klebsiella antigens |
| 01/28/2014 | US8637051 Compositions and methods for treatment of mucosal infections |
| 01/28/2014 | US8637050 Peptide vaccines against group A streptococci |
| 01/28/2014 | US8637049 Attenuated live vaccines for aquatic animals |
| 01/28/2014 | US8637048 Immunizing compositions and methods of use |
| 01/28/2014 | US8637047 Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same |
| 01/28/2014 | US8637046 Bovine herpes virus-1 compositions, vaccines and methods |
| 01/28/2014 | US8637044 Method of generating an immune response in a subject using fusion proteins comprising CD4 minimal modules and HIV Tat scaffold polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes |
| 01/28/2014 | US8637043 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 01/28/2014 | US8637042 Targeted particles and methods of using the same |
| 01/28/2014 | US8637041 Secreted Campylobacter flaggella coregulated proteins as immunogens |
| 01/28/2014 | US8637040 Genus-wide chlamydial peptide vaccine antigens |
| 01/28/2014 | US8637039 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof |
| 01/28/2014 | US8637038 Methods for inhibiting allograft rejection |
| 01/28/2014 | US8637037 Allergens and allergoids from bee venom |
| 01/28/2014 | US8637036 Neutralizing antibodies to HIV-1 and their use |
| 01/28/2014 | US8637035 Anti-dengue virus antibodies |
| 01/28/2014 | US8637034 Pharmaceutical compositions comprising activated-potentiated antibodies to interferon-gamma and S100 protein |
| 01/28/2014 | US8637032 Antagonist anti-CD40 monoclonal antibodies and methods for their use |
| 01/28/2014 | US8637031 Method of treating osteoarthritis with an antibody to NGF |
| 01/28/2014 | US8637030 Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract |
| 01/28/2014 | US8637029 Methods for the treatment of gout |
| 01/28/2014 | US8637028 Adjuvant incorporation in immunonanotherapeutics |
| 01/28/2014 | US8637027 Anti c-Met antibodies |
| 01/28/2014 | US8637026 Anti-C35 antibody combination therapies and methods |
| 01/28/2014 | US8637025 Composition and method for the treatment and prevention of enteric bacterial infections |
| 01/28/2014 | US8637024 Fusion antibodies for HIV therapy |
| 01/28/2014 | US8637023 Hemojuvelin fusion proteins |
| 01/28/2014 | US8637021 Formulations for TACI-immunoglobulin fusion proteins |
| 01/28/2014 | US8637020 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same and methods of use thereof |
| 01/28/2014 | US8637019 Engineered anti-TSLP antibody |
| 01/28/2014 | US8637018 Humanized anti-IL-18 antibodies |
| 01/28/2014 | US8637017 Anti-EpCAM antibodies |
| 01/28/2014 | US8637016 EphA3 antibodies for the treatment of solid tumors |
| 01/28/2014 | US8637015 Methods of antagonizing signal transduction in dorsal root ganglion cells |
| 01/28/2014 | US8637014 Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses |
| 01/28/2014 | US8637013 Treatment of drug-related side effect and tissue damage by targeting the CD24-HMGB1-Siglec10 axis |
| 01/28/2014 | US8637012 Genetic products differentially expressed in tumors and the use thereof |
| 01/28/2014 | US8637011 Modulation of NKG2D |
| 01/28/2014 | US8637006 Recombinant vaccines and use thereof |
| 01/28/2014 | US8636997 Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist |
| 01/28/2014 | US8636979 TLR 4 and 9 receptors agonists for preventing septic complications of post-traumatic immunodepression in patients hospitalized for severe traumatic injuries |